Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 321

1.

CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia.

Ibrahim S, Keating M, Do KA, O'Brien S, Huh YO, Jilani I, Lerner S, Kantarjian HM, Albitar M.

Blood. 2001 Jul 1;98(1):181-6.

2.

Clinical significance of CD38 expression in chronic lymphocytic leukemia.

Del Poeta G, Maurillo L, Venditti A, Buccisano F, Epiceno AM, Capelli G, Tamburini A, Suppo G, Battaglia A, Del Principe MI, Del Moro B, Masi M, Amadori S.

Blood. 2001 Nov 1;98(9):2633-9.

3.

CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.

Domingo-Domènech E, Domingo-Clarós A, Gonzàlez-Barca E, Beneitez D, Alonso E, Romagosa V, De Sanjos S, Petit J, Grañena A, Fernández de Sevilla A.

Haematologica. 2002 Oct;87(10):1021-7.

4.

CD38 as a prognostic factor in Chinese patients with chronic lymphocytic leukaemia.

Xu W, Li JY, Wu YJ, Yu H, Shen QD, Tian T, Li L, Qiu HX.

Leuk Res. 2009 Feb;33(2):237-43. doi: 10.1016/j.leukres.2008.06.026.

PMID:
18674817
5.
6.

Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia.

Ibrahim S, Jilani I, O'Brien S, Rogers A, Manshouri T, Giles F, Faderl S, Thomas D, Kantarjian H, Keating M, Albitar M.

Cancer. 2003 Apr 15;97(8):1914-9.

7.

[Prognositc value of CD38 cell surface marker in chronic lymphocytic leukemia].

Mhes L, Simon A, Rejtö L, Kiss A, Reményi G, Batár P, Telek B, Udvardy M.

Orv Hetil. 2003 Aug 3;144(31):1531-5. Hungarian.

PMID:
14502867
8.

Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia.

Heintel D, Schwarzinger I, Chizzali-Bonfadin C, Thalhammer R, Schwarzmeier J, Fritzer-Szekeres M, Weltermann A, Simonitsch I, Lechner K, Jaeger U.

Leuk Lymphoma. 2001 Nov-Dec;42(6):1315-21.

PMID:
11911414
9.
10.

CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia.

D'Arena G, Musto P, Cascavilla N, Dell'Olio M, Di Renzo N, Perla G, Savino L, Carotenuto M.

Leuk Lymphoma. 2001 Jun;42(1-2):109-14.

PMID:
11699197
11.

Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia.

Lai R, O'Brien S, Maushouri T, Rogers A, Kantarjian H, Keating M, Albitar M.

Cancer. 2002 Sep 1;95(5):1071-5.

12.

The use of CD38 expression by monoclonal B lymphocytes as a prognostic factor in B-cell chronic lymphocytic leukemia.

Boonstra JG, von't Veer MB, Gratama JW.

J Biol Regul Homeost Agents. 2004 Jul-Dec;18(3-4):340-6. Review.

PMID:
15786702
13.

The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemia.

Ferrajoli A, Keating MJ, Manshouri T, Giles FJ, Dey A, Estrov Z, Koller CA, Kurzrock R, Thomas DA, Faderl S, Lerner S, O'Brien S, Albitar M.

Blood. 2002 Aug 15;100(4):1215-9.

14.

V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia.

Kröber A, Seiler T, Benner A, Bullinger L, Brückle E, Lichter P, Döhner H, Stilgenbauer S.

Blood. 2002 Aug 15;100(4):1410-6.

15.

Quantification improves the prognostic value of CD38 expression in B-cell chronic lymphocytic leukaemia.

Mainou-Fowler T, Dignum H, Taylor PR, Dickinson AM, Saunders PW, Proctor SJ, Summerfield GP.

Br J Haematol. 2002 Sep;118(3):755-61.

PMID:
12181042
16.

The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience.

Gentile M, Mauro FR, Calabrese E, De Propris MS, Giammartini E, Mancini F, Milani ML, Guarini A, Foà R.

Br J Haematol. 2005 Aug;130(4):549-57.

PMID:
16098069
17.

CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia.

Chevallier P, Penther D, Avet-Loiseau H, Robillard N, Ifrah N, Mahé B, Hamidou M, Maisonneuve H, Moreau P, Jardel H, Harousseau JL, Bataille R, Garand R.

Br J Haematol. 2002 Jan;116(1):142-50.

PMID:
11841407
18.

Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia.

Jelinek DF, Tschumper RC, Geyer SM, Bone ND, Dewald GW, Hanson CA, Stenson MJ, Witzig TE, Tefferi A, Kay NE.

Br J Haematol. 2001 Dec;115(4):854-61.

PMID:
11843819
19.

Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemia.

Morabito F, Mangiola M, Oliva B, Stelitano C, Callea V, Deaglio S, Iacopino P, Brugiatelli M, Malavasi F.

Leuk Res. 2001 Nov;25(11):927-32.

PMID:
11597727
20.

CD38 expression and Ig VH gene mutation in B-cell chronic lymphocytic leukemia.

Matrai Z, Lin K, Dennis M, Sherrington P, Zuzel M, Pettitt AR, Cawley JC.

Blood. 2001 Mar 15;97(6):1902-3. No abstract available.

Items per page

Supplemental Content

Support Center